Australia  

Johnson & Johnson

U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

Johnson & Johnson    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Johnson & Johnson: U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. J&J is one of the world's most valuable companies.

0
shares
ShareTweetSavePostSend
 

Johnson & Johnson to Discontinue Sales of Talc-Based Baby Powder [Video]

Johnson & Johnson to Discontinue Sales of Talc-Based Baby Powder

The company announced the product will no longer be sold in the US or Canada.

Credit: Cover Video STUDIO     Duration: 01:09Published
AstraZeneca to make billion COVID vaccine doses if tests succeed [Video]

AstraZeneca to make billion COVID vaccine doses if tests succeed

AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage..

Credit: Reuters Studio     Duration: 01:20Published
Johnson & Johnson Announces They Will No Longer Sell Talc Baby Powder In U.S. And Canada [Video]

Johnson & Johnson Announces They Will No Longer Sell Talc Baby Powder In U.S. And Canada

Johnson & Johnson announced on Tuesday they will stop selling their popular talc Baby Powder. According to Reuters, the decision will affect only the United States and Canadian markets. J&J says demand..

Credit: Wochit News     Duration: 00:32Published
J&J to stop selling talc-based baby powder in U.S., Canada [Video]

J&J to stop selling talc-based baby powder in U.S., Canada

Johnson and Johnson on Tuesday said it would stop selling its talc-based Johnson’s Baby Powder in the United States and Canada as part of a broad reassesment of its consumer product portfolio..

Credit: Reuters - Politics     Duration: 01:05Published
Wall Street gain fueled by hopes to ease lockdown [Video]

Wall Street gain fueled by hopes to ease lockdown

Stocks rallied led by a four percent surge in the Nasdaq with investors encouraged by talks on how to end the lockdown. Conway G. Gittens has the market wrap.

Credit: Reuters Studio     Duration: 02:31Published
UK's Prime Minister Johnson Johnson Recovering From COVID-19 [Video]

UK's Prime Minister Johnson Johnson Recovering From COVID-19

According to Reuters, British Prime Minister Boris Johnson is doing better, making good progress in his COVID-19 recovery. On Saturday, Johnson's health minister shared the news, adding that the peak..

Credit: Wochit News     Duration: 00:35Published

You Might Like


Judge orders Johnson & Johnson to issue graphic warnings on pelvic mesh products

The new warnings should be in place by March 20, the Federal Court said on Friday. Johnson & Johnson may seek further time in which to comply.
The Age - Published

Johnson & Johnson to pay out $2.6m over vaginal mesh implants

The Federal Court has ordered US pharmaceutical giant Johnson & Johnson to pay $2.6 million in damages to three Australian women who received faulty pelvic mesh implants.
SBS - Published Also reported by •The Age

Johnson & Johnson ordered to pay $2.6m

The Federal Court has ordered Johnson & Johnson to pay $2.6 million in damages to three women who received faulty pelvic mesh implants.
SBS - Published

Johnson & Johnson partners with U.S. agency to develop coronavirus vaccine

Johnson & Johnson said on Tuesday it was working with the Biomedical Advanced Research and Development Authority (BARDA) to speed up development of a coronavirus vaccine.
Reuters - Published

Where were the regulators? How authorities failed pelvic mesh victims

It was a damning judgment against Johnson & Johnson, but also an indictment on the federal agencies that need to protect Australians from harm.
The Age - Published

Johnson & Johnson lose pelvic mesh case to women in landmark judgment

The courtroom was packed with mesh-injured women, representing just a portion of those involved in the class action.
The Age - Published

Tasmanian poppy farmers should not depend on 'death, addiction', say Greens

After Johnson & Johnson copped an $845 million fine, one lawyer said the US opioid crisis 'began in Tasmania' - the world's hub for legal opium poppies.
The Age - Published